Breast Implants and Reconstructive Devices – Market Insights – Europe

The European market for breast implants and reconstruction devices will exhibit modest growth, driven by several key factors. The safety and aesthetic results of breast augmentation and reconstruction procedures have been significantly improved through technological advancements and the expanded availability of products. Manufacturers are also investing in product development to improve implant safety and efficacy, as well as assessing both existing and emerging products in clinical studies. These dynamics, along with the evolving regulatory landscape, support product sales over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for breast implant and reconstructive device in Europe from 2019 through 2032.

Various factors are driving demand for breast implant and reconstruction surgery, supporting treatment volumes.

What factors are contributing to the rising awareness and acceptance of these procedures in the region?

What types of technologies are supporting demand for breast implant and reconstruction?

Increasing patient safety and mitigating post-implantation complications are important considerations for the industry.

What measures are being taken to enhance patient safety in breast implant and reconstructive device procedures in Europe?

What strategies are companies using to demonstrate the safety and efficacy of their products?

Regulatory changes in Europe have impacted the breast implant and reconstructive device market.

How have manufacturers and healthcare professionals adapted to these regulatory changes?

What impact will this have on the market and competitive dynamics?

Table of contents

Breast Implants and Reconstructive Devices - Market Insights - Europe

Meenu Sankar, MS

Meenu Sankar is a senior analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Clarivate, specializing in the large-joint reconstruction, dental, and aesthetics markets. Meenu holds a Bachelor’s degree in Pharmaceutical Sciences from Manipal University and a Master’s degree in Biomedicine from The University of Skövde, Sweden.

Follow Meenu on Twitter: @meenu_sankarDRG

Contact sales Login to access report

Back to all Medtech Insights reports